Related references
Note: Only part of the references are listed.Changes in Cerebral Gray and White Matter in Patients with Pantothenate Kinase-Associated Neurodegeneration: A Long-Term Magnetic Resonance Imaging Follow-Up Study
Pedro Roa-Sanchez et al.
JOURNAL OF MOVEMENT DISORDERS (2021)
MRI of neurodegeneration with brain iron accumulation
Stephane Lehericy et al.
CURRENT OPINION IN NEUROLOGY (2020)
Mitochondrial Dysfunction, Oxidative Stress and Neuroinflammation in Neurodegeneration with Brain Iron Accumulation (NBIA)
Isabel Hinarejos et al.
ANTIOXIDANTS (2020)
Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study
Thomas Klopstock et al.
LANCET NEUROLOGY (2019)
Neurodegeneration with brain iron accumulation: Insights into the mitochondria dysregulation
Zhi-Bin Wang et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Iron overload in transfusion-dependent patients
Thomas D. Coates
Hematology-American Society of Hematology Education Program (2019)
Classification and molecular pathogenesis of NBIA syndromes
Ivano Di Meo et al.
EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY (2018)
Efficacy and safety of deferiprone for the treatment of pantothenate kinase-associated neurodegeneration (PKAN) and neurodegeneration with brain iron accumulation (NBIA): Results from a four years follow-up
Giovanni Cossu et al.
PARKINSONISM & RELATED DISORDERS (2014)
Neuroimaging Features of Neurodegeneration with Brain Iron Accumulation
M. C. Kruer et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2012)
A pilot trial of deferiprone for neurodegeneration with brain iron accumulation
Giovanni Abbruzzese et al.
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL (2011)
Iron-Related MRI Images in Patients with Pantothenate Kinase-Associated Neurodegeneration (PKAN) Treated with Deferiprone: Results of a Phase II Pilot Trial
Giovanna Zorzi et al.
MOVEMENT DISORDERS (2011)
Clinical and genetic delineation of neurodegeneration with brain iron accumulation
A. Gregory et al.
JOURNAL OF MEDICAL GENETICS (2009)
Regression of symptoms after selective iron chelation therapy in a case of neurodegeneration with brain iron accumulation
Gian Luca Forni et al.
MOVEMENT DISORDERS (2008)
T2*and FSE MRI distinguishes four subtypes of neurodegeneration with brain iron accumulation
A. McNeill et al.
NEUROLOGY (2008)
Selective iron chelation in Friedreich ataxia:: biologic and clinical implications
Nathalie Boddaert et al.
BLOOD (2007)
Neurodegenerative disease and iron storage in the brain
M Thomas et al.
CURRENT OPINION IN NEUROLOGY (2004)
Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome.
SJ Hayflick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Share Paper
